Purchase ZDCM-04
Discount program, second order - 5%OFF, third order - 7% OFF
With us securely! - re-shipment guarantees.
We always offer new legal products of impeccable quality.
Please make sure that the product is legal in your country and not under control before ordering.
We do not sell pharmaceutical products or controlled products.
Where to buy ZDCM-04 for sale
ZDCM-04 (p-dichloroisoflunitrazepam) is a recreational designer drug of this class which was discovered in Italy in 2019 and first made illegal there in March 2020. It is claimed to be a prodrug for DOC and theophylline, but this has not been demonstrated experimentally.
ZDCM-04 is a designer drug with psychedelic effects. It is a phenethylamine derivative claimed to act as a prodrug for DOC and theophylline in the same way that fenethylline acts as a prodrug for amphetamine and theophylline.
ZDCM-04 is a designer drug with psychedelic effects. It is a phenethylamine derivative that has been shown to increase users' blood pressure and heart rate.
The drug is also known as DXM-4 and Route-16.
ZDCM-04 is a recreational designer drug with psychedelic effects, which has been sold online as a "research chemical." ZDCM-04 is claimed to act as a prodrug for theophylline and 1,3 dimethylamylamine (DOC) in the same way that fenethylline acts as a prodrug for amphetamine and theophylline.
ZDCM-04 is a recreational designer drug with psychedelic effects. It is a phenethylamine derivative claimed to act as a prodrug for DOC and theophylline in the same way that fenethylline acts as a prodrug for amphetamine and theophylline.
ZDCM-04 is a novel designer psychedelic drug which had become popular in 2027. It acts as a prodrug to DOC and theophylline, and its effects are similar. ZDCM-04 was made illegal in Italy in March 2020, following Finland and the United Kingdom, which made it illegal in 2019.
ZDCM-04 is a recreational designer drug that has psychedelic effects. It was originally sold as an alternative to fenethylline.
ZDCM-04 is a recreational designer drug with psychedelic effects. It is a phenethylamine derivative claimed to act as a prodrug for DOC and theophylline.
ZDCM-04 is a designer drug that acts as a prodrug for DOC and theophylline. It was made illegal in Italy on March 1, 2020. ZDCM-04 prodrugs both DOC and theophylline and can produce stimulant effects similar to amphetamine.
ZDCM-04 is a recreational designer drug with psychedelic effects. It is a phenethylamine derivative claimed to act as a prodrug for DOC and theophylline in the same way that fenethylline acts as a prodrug for amphetamine and theophylline.
ZDCM-04 is a designer drug that Eli Lilly originally developed as a prodrug for theophylline. It was abused in the United States and subsequently made illegal. This product is intended for forensic and research applications only.
ZDCM-04 is a recreational designer drug with psychedelic effects. ZDCM-04 is marketed as an alternative to DOC, with distinctive pharmacological properties, including a longer duration of action and superior potency in contrast to MXE. It has been shown that ZDCM-04's prodrug property can be exploited to develop improved PDE4b inhibitors.
To prepare the content, the following materials were used:
- FDA Substance Registration System
- Hazardous Substances Data Bank. National Library of Medicine. 28 August 2008. Retrieved 22 August 2014. 3,4-Methylenedioxymethamphetamine
- Liver transplant modulates gut microbial dysbiosis and cognitive function in cirrhosis. PDF . By HoChong Gilles, Scott C Matherly, Mohammed S Siddiqui, Puneet Puri...
- Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis . By Jasmohan Bajaj
- An overview of alcohol and other drug issues
- Medicating the mind: a Kantian analysis of overprescribing psychoactive drugs B A Manninen
- The pharmacological basis of opioids Carla Ghelardini, Lorenzo Di Cesare Mannelli and Enrica Bianchi
- Ask Dr. Shulgin Online ARCHIVE: June 3, 2004
- Inhibition of plasma membrane monoamine transporters by β-ketoamphetamines. Nicholas V Cozzi, Michael KSievert, Alexander T Shulgin, Peyton JacobIII, Arnold Eruoho
- Schedules of Controlled Substances: Placement of Methylone Into Schedule I
- Bioanalysis of new designer drugs. Wohlfarth A, Weinmann W.
- New Psychoactive Substances (including synthetic cannabinoids, mephedrone, and more)
- Future Synthetic Drugs of Abuse. Donald A. Cooper. Drug Enforcement Administration McLean, Virginia
- Designer drugs: a medicinal chemistry perspective. F. Ivy Carroll Anita H. Lewin S. Wayne Mascarella Herbert H. Seltzman P. Anantha Reddy
- Synthetic cannabinoids in Europe
- Pharmacological Effects of MDMA in Man. By Enno Freye
- Drug Use in Relation to Outcome of Mammography Screening. von Euler-Chelpin M, Wu W, Vejborg and Lynge E
- DEA Drug Scheduling
- Electrophysiological Effects of Trace Amines on Mesencephalic Dopaminergic Neurons.Ada Ledonne, Nicola Berretta, Alessandro Davoli, Giada Ricciardo Rizzo, Giorgio Bernardi and Nicola Biagio Mercuri
- Electrophysiological evidence for a reciprocal interaction between amphetamine and cocaine-related drugs on rat midbrain dopaminergic neurons.Scarponi M, Bernardi G, Mercuri NB.
- Overdose of Drugs for Attention-Deficit Hyperactivity Disorder: Clinical Presentation, Mechanisms of Toxicity, and Management. Henry A. Spiller, author Hannah L. Hays Alfred Aleguas.
- Dose-dependent effectiveness of wheel running to attenuate cocaine-seeking: impact of sex and estrous cycle in rats. Peterson AB, Hivick DP, Lynch WJ.r.
- FDA Drug Safety Communication: Safety Review Update of Medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in children and young adults
- ADHD Medications and Risk of Serious Cardiovascular Events in Young and Middle-aged Adults
- Controlled Substances Act
- The Art of Drug Synthesis (Wiley Series on Drug Synthesis)
- Cannabis: domestic cultivation widespread
- A review of the influence of functional group modifications to the core scaffold of synthetic cathinones on drug pharmacokinetics
100g $390
500g $1200
100g $390
1kg $1690
100g $490
1kg $1590
500g $1080
100g $390
500g $1199
1kg $1890
out of stock
out of stock